HLTH 8-K Webmd Reports Third Quarter Results

Exhibit 99.2

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2004		2003			2004		2003
Revenue	$	299,615	$	250,635		$	852,710	$	705,584
Costs and expenses:
Cost of operations		168,571		149,270			495,174		410,556
Development and engineering		14,392		11,334			38,479		32,654
Sales, marketing, general and administrative		84,762		72,450			245,054		209,917
Depreciation, amortization and other		15,189		11,097			40,922		52,961
Legal expense		2,325		493			6,577		493
Restructuring and integration charge		4,535		—			4,535		—
Interest income		4,512		6,401			14,506		16,434
Interest expense		4,843		4,703			14,429		10,444
Other income, net		94		3,039			578		4,340
Income from continuing operations before income tax provision		9,604		10,728			22,624		9,333
Income tax provision		1,435		1,273			2,979		3,261
Income from continuing operations		8,169		9,455			19,645		6,072
Loss from discontinued operations, net of income taxes		—		3,366			—		33,611
Net income (loss)	$	8,169	$	6,089		$	19,645	$	(27,539	)
Basic income (loss) per common share:
Income from continuing operations	$	0.03	$	0.03		$	0.06	$	0.02
Loss from discontinued operations		—		(0.01	)		—		(0.11	)
Net income (loss)	$	0.03	$	0.02		$	0.06	$	(0.09	)
Diluted income (loss) per common share:
Income from continuing operations	$	0.02	$	0.03		$	0.06	$	0.02
Loss from discontinued operations		—		(0.01	)		—		(0.10	)
Net income (loss)	$	0.02	$	0.02		$	0.06	$	(0.08	)
Weighted-average shares outstanding used in computing income (loss) per common share:
Basic		312,366		305,471			311,379		304,121
Diluted		333,978		328,463			333,048		326,396

WebMD CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2004			2003			2004			2003
Revenues
Transaction services	$	174,643		$	131,977		$	504,459		$	365,491
Physician services		76,924			75,487			219,703			224,295
Portal services		37,017			31,164			95,178			79,882
Plastic technologies		19,385			19,093			58,543			55,015
Inter-segment eliminations		(8,354	)		(7,086	)		(25,173	)		(19,099	)
	$	299,615		$	250,635		$	852,710		$	705,584
Income (loss) before restructuring, taxes, non-cash and other items
Transaction services	$	31,750		$	21,767		$	90,514		$	68,160
Physician services		5,856			3,686			8,978			16,342
Portal services		10,040			8,712			22,208			18,922
Plastic technologies		5,823			5,690			17,140			15,857
Corporate		(15,170	)		(12,809	)		(42,703	)		(37,652	)
Interest income		4,512			6,401			14,506			16,434
Interest expense		(4,843	)		(4,703	)		(14,429	)		(10,444	)
	$	37,968		$	28,744		$	96,214		$	87,619
Basic income per common share before restructuring, taxes, non-cash and other items (a)	$	0.12		$	0.09		$	0.31		$	0.29
Diluted income per common share before restructuring, taxes, non-cash and other items (a)	$	0.11		$	0.09		$	0.29		$	0.27
Restructuring, taxes, non-cash and other items (b)
Depreciation, amortization and other	$	(15,189	)	$	(11,097	)	$	(40,922	)	$	(52,961	)
Amortization of prepaid content and services (included in cost of operations)		(104	)		(1,105	)		(705	)		(1,932	)
Amortization of prepaid content and services (included in sales, marketing, general and administrative)		(3,505	)		(4,970	)		(14,188	)		(16,292	)
Non-cash stock compensation (included in sales, marketing, general and administrative)		(2,800	)		(3,390	)		(7,241	)		(10,948	)
Legal expense		(2,325	)		(493	)		(6,577	)		(493	)
Restructuring and integration charge		(4,535	)		—			(4,535	)		—
Income tax provision		(1,435	)		(1,273	)		(2,979	)		(3,261	)
Other income, net		94			3,039			578			4,340
Income from continuing operations		8,169			9,455			19,645			6,072
Loss from discontinued operations, net of income taxes		—			(3,366	)		—			(33,611	)
Net income (loss)	$	8,169		$	6,089		$	19,645		$	(27,539	)
Basic income (loss) per common share:
Income from continuing operations	$	0.03		$	0.03		$	0.06		$	0.02
Loss from discontinued operations		—			(0.01	)		—			(0.11	)
Net income (loss)	$	0.03		$	0.02		$	0.06		$	(0.09	)
Diluted income (loss) per common share:
Income from continuing operations	$	0.02		$	0.03		$	0.06		$	0.02
Loss from discontinued operations		—			(0.01	)		—			(0.10	)
Net income (loss)	$	0.02		$	0.02		$	0.06		$	(0.08	)
Weighted-average shares outstanding used in computing income (loss) per common share:
Basic		312,366			305,471			311,379			304,121
Diluted		333,978			328,463			333,048			326,396

(a)	Basic and diluted income per common share before restructuring, taxes, non-cash and other items is based on the weighted-average shares outstanding used in computing basic and diluted income (loss) per common share.
(b)	Reconciliation of income before restructuring, taxes, non-cash and other items to income from continuing operations.

WebMD CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

	September 30,		December 31,
	2004		2003
	(Unaudited)		(Audited)
Assets
Cash and cash equivalents	$	108,204	$	63,298
Short-term investments		25,784		207,383
Accounts receivable, net		203,288		181,173
Inventory		12,579		12,158
Current portion of prepaid content and distribution services		16,221		18,116
Other current assets		24,978		25,973
Total current assets		391,054		508,101
Marketable debt securities		515,096		451,290
Marketable equity securities		3,373		4,744
Property and equipment, net		83,071		77,278
Prepaid content and distribution services		19,020		31,992
Goodwill		959,799		844,448
Intangible assets, net		270,426		184,130
Other assets		35,800		33,323
	$	2,277,639	$	2,135,306
Liabilities and Stockholders’ Equity
Accounts payable	$	10,777	$	10,390
Accrued expenses		207,271		208,430
Deferred revenue		104,794		86,708
Total current liabilities		322,842		305,528
Convertible subordinated notes		649,999		649,999
Other long-term liabilities		974		1,182
Convertible redeemable exchangeable preferred stock		98,240		—
Stockholders’ equity		1,205,584		1,178,597
	$	2,277,639	$	2,135,306

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Nine Months Ended
	September 30,
	2004			2003
Cash flows from operating activities:
Net income (loss)	$	19,645		$	(27,539	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss from discontinued operations		—			33,611
Depreciation, amortization and other		40,922			52,961
Amortization of debt issuance costs		2,255			1,505
Non-cash content and distribution services		14,893			18,224
Non-cash stock-based compensation		7,241			10,948
Gain on investments		(457	)		(3,222	)
Gain on sale of property and equipment		(121	)		—
Changes in operating assets and liabilities:
Accounts receivable		(8,001	)		3,580
Inventory		(417	)		(1,144	)
Prepaid content and distribution services		(26	)		(537	)
Accounts payable		(874	)		(775	)
Accrued expenses		(8,189	)		(12,174	)
Deferred revenue		9,284			(2,228	)
Other, net		3,045			5,685
Net cash provided by continuing operations		79,200			78,895
Net cash provided by discontinued operations		—			5,130
Net cash provided by operating activities		79,200			84,025
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		384,238			11,322
Proceeds from maturities and redemptions of held-to-maturity securities		—			157,919
Purchases of available-for-sale securities		(274,600	)		(7,754	)
Purchases of held-to-maturity securities		—			(590,113	)
Purchases of property and equipment		(24,889	)		(13,643	)
Proceeds received from sale of property and equipment		417			—
Proceeds received from sale of discontinued operations		—			46,500
Cash paid in business combinations, net of cash acquired		(225,375	)		(133,471	)
Other changes in equity of discontinued operations		—			1,754
Net cash used in continuing operations		(140,209	)		(527,486	)
Net cash used in discontinued operations		—			(2,529	)
Net cash used in investing activities		(140,209	)		(530,015	)
Cash flows from financing activities:
Proceeds from issuance of common stock		30,528			35,367
Net proceeds from issuance of preferred stock		98,115			—
Payments of notes payable and other		(433	)		(211	)
Purchases of treasury shares		(22,267	)		(18,125	)
Net proceeds from issuance of convertible debt		—			339,125
Net cash provided by continuing operations		105,943			356,156
Net cash used in discontinued operations		—			(6,546	)
Net cash provided by financing activities		105,943			349,610
Effect of exchange rates on cash		(28	)		711
Net increase (decrease) in cash and cash equivalents		44,906			(95,669	)
Changes in cash attributable to discontinued operations		—			3,945
Cash and cash equivalents at beginning of period		63,298			175,596
Cash and cash equivalents at end of period	$	108,204		$	83,872